Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy

Indian Journal of Ophthalmology

Volumn 60, Issue 1, 2012, Pages 45-48

  Damkondwar, Deepali R ^a   Raman, Rajiv ^a   Suganeswari, G ^a   Kulothungan, Vaitheeswaran ^b   Sharma, Tarun ^a  

^a SANKARA NETHRALAYA   (India)

^b Elite School of Optometry   (India)

Author keywords

Cardiovascular disease; diabetes; diabetic retinopathy; framingham risk score

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INDIA; MALE; METHODOLOGY; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84856013648     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.91344     Document Type: Article

References (21)

1. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000;160:1093-100. (Pubitemid 30227018)
2. Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005;366:1744-9. (Pubitemid 41587455)
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-53. (Pubitemid 33108145)
4. Grundy SM. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46. (Pubitemid 29416243)
5. Selvin E. Meta-Analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
6. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006;124:235-44. (Pubitemid 44734280)
7. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64. (Pubitemid 33126663)
8. Collins P. Management of cardiovascular risk in the perimenopausal woman: A consensus statement of European cardiologists and gynaecologists. Eur Heart J 2007;28:2028-40. (Pubitemid 47579557)
9. Kanjilal S, Rao VS, Mukherjee M, Natesha BK, Renuka KS, Sibi K, et al. Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians. Vasc Health Risk Manag 2008;4:199-211. (Pubitemid 351460861)
10. Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC Jr; ARIC Investigators. Declining severity of myocardial infarction from 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009;119:503-14.
11. Chamnan P, Simmons RK, Sharp SJ, Griffin SJ, Wareham NJ. Cardiovascular risk assessment score for people with diabetes: A systemic review. Diabetologia 2009;52:2001-14.
12. Agarwal S. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN DREAMS I): Study design and research methodology. Ophthalmic Epidemiol 2005;12:143-53. (Pubitemid 41702827)
13. McGuire DK, Granger CB. Diabetes and ischemic heart disease. Am Heart J 1999;138:S366-75. (Pubitemid 29523301)
14. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-47. (Pubitemid 28213628)
15. Eichler K, Puhan MA, Steurer J, Bachmann LM. Prediction of first coronary events with the Framingham score: A systematic review. Am Heart J 2007;153:722-31.
16. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007;30:1292-3.
17. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: Results from a United Kingdom study. Diabet Med 2005;22:554-62. (Pubitemid 40593130)
18. McEwan P, Williams JE, Griffiths JD, Bagust A, Peters JR, Hopkinson P, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004;21:318-23. (Pubitemid 38519665)
19. Jimeno Mollet J, Molist Brunet N, Franch Nadal J, Serrano Borraz V, Serrano Barragán L, Gracia Giménez R. Variability in the calculation of coronary risk in type-2 diabetes mellitus. Aten Primaria 2005;35:30-6. (Pubitemid 40293146)
20. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study. Diabetes Care 2007;30:1742-6. (Pubitemid 47036346)
21. Gimeno-Orna JA, Faure-Nogueras E, Castro-Alonso FJ, Boned- Juliani B. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus. Am J Cardiol 2009;103:1364-7.